IEQ Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCRX
JHC
IEQ Capital's BCRX Position: Q3 2026 in Review
IEQ Capital reduced its BioCryst Pharmaceuticals (BCRX) stake by 66% in Q3 2026, selling an estimated $1.42M and leaving 76,838 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.
IEQ Capital first reported a position in BCRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.27M in Q2 2026. 333 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.
- IEQ Capital held 76,838 shares of BioCryst Pharmaceuticals worth $640K as of Q3 2026.
- IEQ Capital sold 150,583 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $1.42M.
- BioCryst Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1247 holding.
- IEQ Capital first reported a position in BioCryst Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
- IEQ Capital's BioCryst Pharmaceuticals position peaked at $2.27M in Q2 2026.
- 333 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.